Abeona Therapeutics

Abeona Therapeutics is a clinical-stage biopharmaceutical company that develops gene and cell therapies for life-threatening rare genetic diseases. It was incorporated in 1974 and is headquartered in New York, New York.
Abeona Therapeutics stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Abeona Therapeutics balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Abeona Therapeutics cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Abeona Therapeutics multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Abeona Therapeutics profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Abeona Therapeutics assets
Abeona Therapeutics cash flows

Abeona Therapeutics dividend policy

The company doesn't provide dividend

Abeona Therapeutics shares

TickerNameTypeNominal valueISINPrice
ABEO:USAbeona TherapeuticsCommon share-US00289Y1073$7.61
Abeona Therapeutics news
13.05.2022
Abeona Therapeutics' GAAP loss for 3 months of 2022 was $20.791 million, up 29.9% from $16.002 million in the previous year. Revenues were $346,000. The company did not generate revenues a year earlier.
Source: {source} pictogram investors.abeonatherapeutics.com
Pictogram next
31.03.2022
Abeona Therapeutics' GAAP loss for 2021 was $84.936 million, up 0.8% from $84.234 million in the prior year. Revenue declined 70% to $3 million from $10 million a year earlier.
Source: {source} pictogram investors.abeonatherapeutics.com
Pictogram next
15.11.2021
Abeona Therapeutics' GAAP loss for 9M 2021 was $38.253 million, down 44.1% from $68.406 million in the prior year. The company did not generate revenue. A year earlier the figure was $7 million.
Source: {source} pictogram investors.abeonatherapeutics.com
Pictogram next
29.07.2021
Abeona Therapeutics' GAAP net income for 6 months of 2021 was $31.209 million, down 49% from $61.169 million in the prior year.
Source: {source} pictogram investors.abeonatherapeutics.com
Pictogram next
All Abeona Therapeutics news
General information
Company nameAbeona Therapeutics
Tags#pharmacy, #biotechnology
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address1330 Avenue of the Americas 33rd Floor New York, NY 10019 United States
Mailing address1330 Avenue of the Americas 33rd Floor New York, NY 10019 United States
Websiteinvestors.abeonatherapeutics.com
Information disclosurewww.sec.gov